White label – Pompe disease - ClinicalTrials.eu

Study of Milademetan and Fulvestrant for Patients with Advanced or Metastatic Breast Cancer with GATA3 Mutation, ER-Positive, HER2-Negative

Not recruiting

2 1 1 1
Investigated Diseases:
- HER2 negative breast cancer
Investigated Drugs:
- Milademetan
- Fulvestrant
Study on PRAX-628 for Epilepsy Patients with Light-Induced EEG Response

Not recruiting

2 1
Investigated Diseases:
- Epilepsy
Investigated Drugs:
- Prax-628
Study on KTE-X19 CAR-T Cell Therapy for Patients with Relapsed or Refractory Mantle Cell Lymphoma Responding Partially to Ibrutinib

Not recruiting

2 1 1 1
Investigated Diseases:
Investigated Drugs:
Study of Peginterferon Alfa-2a for Patients with Extramembranous Glomerulonephritis

Not recruiting

2 1 1 1
Investigated Diseases:
- Glomerulonephritis membranous
Investigated Drugs:
- Peginterferon Alfa-2A
Study Comparing DZD9008 and Chemotherapy for First-Line Treatment in Patients with Advanced Non-Small Cell Lung Cancer with EGFR Exon 20 Mutation

Not recruiting

3 1 1 1
Investigated Diseases:
- Non-small cell lung cancer
Investigated Drugs:
+3
Study on the Effectiveness and Safety of AP707, Amitriptyline, and Capsaicin for Patients with Chronic Pain from Diabetic Neuropathy

Not recruiting

3 1 1
Investigated Diseases:
- Diabetic neuropathy
- Pain
Investigated Drugs:
Continued Treatment Study for Adults with Advanced Cancer Using Pemigatinib

Not recruiting

2 1 1 1
Investigated Diseases:
- Neoplasm malignant
Investigated Drugs:
- Pemigatinib
Study on Secukinumab and Prednisone for Patients with Polymyalgia Rheumatica Who Have Recently Relapsed

Not recruiting

3 1 1 1
Investigated Drugs:
- Secukinumab
- Prednisone
+9
Study on Personalized Anti-Platelet Therapy with Prasugrel, Clopidogrel, and Ticagrelor for Patients with Stable Coronary Artery Disease Undergoing Stenting

Not recruiting

3 1 1 1
Investigated Diseases:
- Chronic coronary syndrome
- Coronary artery disease
Investigated Drugs:
Study on the Safety and Effectiveness of SKB264 and Pembrolizumab for Patients with Cervical, Urothelial, Ovarian, or Prostate Cancer

Not recruiting

2 1 1 1
Investigated Diseases:
Investigated Drugs:

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies